Sign in

CIK 0001664710 · Non-accelerated filer<br>Smaller reporting company

Keros Therapeutics, Inc.

Sign in to watch
Ticker
KROS
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
operating
EIN
811173868
Phone
617-314-6297
Business address
1050 WALTHAM STREET, SUITE 302, LEXINGTON, MA, 02421
  1. 144 Insider Sale of Securities
  2. 144 Insider Sale of Securities
  3. 8-K Event Shareholder vote results
  4. 8-K Event Regulation FD disclosure
  5. 4 Insider Changes in Ownership
  6. SCHEDULE 13G Stake Statement of Beneficial Ownership
  7. 10-Q Report Quarterly Report
  8. 8-K Event Results of operations
  9. ARS Other Annual Report to Security Holders
  10. DEFA14A Proxy Proxy Materials
  11. DEF 14A Proxy Proxy Statement
  12. 4 Insider Changes in Ownership
  13. SCHEDULE 13G Stake Statement of Beneficial Ownership
  14. 4 Insider Changes in Ownership
  15. 144 Insider Sale of Securities
  16. 4/A Insider Changes in Ownership
  17. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  18. 4 Insider Changes in Ownership
  19. 3 Insider Initial Statement of Ownership
  20. 4 Insider Changes in Ownership

Page 3 of 27 · 536 filings